Before looking at any specific deals I wanted a practical list of questions to ask. The post at https://thelsmgroup.com/blog/investing-in-healthcare-startups-where-smart-money-is-going offers a short diligence checklist: where the company really sits on its regulatory pathway, whether there is a defined reimbursement or payer strategy, what clinical or real-world validation exists, whether the team balances domain and operating experience, how much runway the current raise provides to the next real milestone, and who the plausible follow-on investors or acquirers are. It also describes how The LSM Group applies domain-expert vetting and milestone mapping before deals reach its syndicate. Straightforward resource for anyone evaluating healthcare startup exposure.
Before looking at any specific deals I wanted a practical list of questions to ask. The post at https://thelsmgroup.com/blog/investing-in-healthcare-startups-where-smart-money-is-going offers a short diligence checklist: where the company really sits on its regulatory pathway, whether there is a defined reimbursement or payer strategy, what clinical or real-world validation exists, whether the team balances domain and operating experience, how much runway the current raise provides to the next real milestone, and who the plausible follow-on investors or acquirers are. It also describes how The LSM Group applies domain-expert vetting and milestone mapping before deals reach its syndicate. Straightforward resource for anyone evaluating healthcare startup exposure.